A randomised, controlled trial of the effects of a mobile telehealth intervention on clinical and patient-reported outcomes in people with poorly controlled diabetes.
Source: Baron, J. S., et al. 2017 - Pubmed ID: 26880694
Setting: UK, Diabetes clinic
RCT
Follow up: 9 months
Sample size:
Total: 81(71)
IG: 45 (40)
CG: 36 (31)
Inclusion criteria:
- Diabetes type 1 or 2
- Hba1c>7.5%
Home monitoring (Mobile telehealth (MTH))
- Storing and transmitting data
- Colour-coded graphical feedback
Phone consultation
- Clinical data review
- Education
Intervention: Data on BP and BG recorded and stored by patients. Nurse accessed data via web and provided feedback on the clinical readings (as needed) and education on lifestyle changes (six weekly calls). The nurse supported insulin titration. An engineer delivered devices/equipment and training.
Duration: NA
Add on: +
Control group: Usual care (Follow-up appointments with nurse every 3-4. months, 1-2 annual appointments with diabetes consultants)
Clinical effect:
- HbAIc →
- Systolic Bp →
- Diastolic Bp→
- Daily insulin dose →
- SF12v2 physical →
- SF12c2 Mental →
- DHP-18-Barriers to activity →
- DHP-18-Disinhibited eating →
- DHP-18-psychological distress →
- CESD-10 →
- STAI-6 →
Patient safety: NA
Patient experiences: NA
Staff experiences: NA
Investment:
Equipment
- BG meter
- BP monitor
- Bluetooth cradle
Staff resources
- Education/training
Running:
Staff resources
- Telephone call
- Data monitoring
- Technical assistance
Organization: NA
Health care utilization:
- Diabetes outpatient appointments →